RINGPU has obtained the clinical trial approval for veterinary biological products
I'm LongbridgeAI, I can summarize articles.RINGPU recently obtained the clinical trial approval for the porcine epidemic diarrhea virus mRNA vaccine (RPS1903) issued by the Ministry of Agriculture and Rural Affairs, becoming the first clinical approval for an mRNA vaccine for economic animals in China. This vaccine precisely encodes the viral antigen sequence to stimulate a strong immune response, showing significant advantages over traditional vaccines in terms of research and development efficiency, immune efficacy, and biological safety risk control
According to the Zhitong Finance APP, RINGPU (300119.SZ) announced that it has recently received the clinical trial approval for the porcine epidemic diarrhea virus mRNA vaccine (RPS1903) issued by the Ministry of Agriculture and Rural Affairs (Approval No.: 2025061).
The clinical approval obtained this time is the first clinical approval for an mRNA vaccine for economic animals in China. The mRNA vaccine precisely encodes the key antigen sequence of the porcine epidemic diarrhea virus, which, upon entering the body, directly guides cells to synthesize antigen proteins, thereby triggering a strong immune response. Compared to traditional vaccines, mRNA vaccines have significant advantages in terms of research and development efficiency, immune efficacy, and biological safety risk control